1. Home
  2. TNGX vs SMR Comparison

TNGX vs SMR Comparison

Compare TNGX & SMR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TNGX
  • SMR
  • Stock Information
  • Founded
  • TNGX 2014
  • SMR 2007
  • Country
  • TNGX United States
  • SMR United States
  • Employees
  • TNGX 140
  • SMR N/A
  • Industry
  • TNGX Biotechnology: Pharmaceutical Preparations
  • SMR Electrical Products
  • Sector
  • TNGX Health Care
  • SMR Industrials
  • Exchange
  • TNGX Nasdaq
  • SMR Nasdaq
  • Market Cap
  • TNGX 747.9M
  • SMR 960.6M
  • IPO Year
  • TNGX N/A
  • SMR N/A
  • Fundamental
  • Price
  • TNGX $6.98
  • SMR $13.15
  • Analyst Decision
  • TNGX Strong Buy
  • SMR Buy
  • Analyst Count
  • TNGX 8
  • SMR 5
  • Target Price
  • TNGX $15.14
  • SMR $10.50
  • AVG Volume (30 Days)
  • TNGX 1.3M
  • SMR 6.4M
  • Earning Date
  • TNGX 11-06-2024
  • SMR 11-06-2024
  • Dividend Yield
  • TNGX N/A
  • SMR N/A
  • EPS Growth
  • TNGX N/A
  • SMR N/A
  • EPS
  • TNGX N/A
  • SMR N/A
  • Revenue
  • TNGX $42,509,000.00
  • SMR $13,856,000.00
  • Revenue This Year
  • TNGX $18.15
  • SMR N/A
  • Revenue Next Year
  • TNGX N/A
  • SMR $197.71
  • P/E Ratio
  • TNGX N/A
  • SMR N/A
  • Revenue Growth
  • TNGX 26.16
  • SMR N/A
  • 52 Week Low
  • TNGX $5.15
  • SMR $1.81
  • 52 Week High
  • TNGX $13.01
  • SMR $16.91
  • Technical
  • Relative Strength Index (RSI)
  • TNGX 33.20
  • SMR 68.00
  • Support Level
  • TNGX $6.72
  • SMR $11.12
  • Resistance Level
  • TNGX $7.78
  • SMR $13.10
  • Average True Range (ATR)
  • TNGX 0.56
  • SMR 1.36
  • MACD
  • TNGX -0.11
  • SMR 0.24
  • Stochastic Oscillator
  • TNGX 8.48
  • SMR 92.64

About TNGX Tango Therapeutics Inc.

Tango Therapeutics Inc is a biotechnology company. It is dedicated towards discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer. It is engaged in the business of discovering and developing precision oncology therapies. Its program TNG908, is an MTA-cooperative inhibitor of PRMT5 designed to work selectively in cancer cells with an MTAP deletion. Its pipeline further consists of discovery programs such as, TNG462, TNG348, TNG260 and others for multiple cancer types with limited treatment options.

About SMR NuScale Power Corporation

NuScale Power Corp is engaged in the development of a new modular light water reactor nuclear power plant to supply energy for electrical generation, district heating, desalination, hydrogen production, and other process heat applications.

Share on Social Networks: